1. BioCryst
BioCryst Pharmaceuticals (NASDAQ:BCRX), in the biotech vaccine area, on Tuesday popped to 5.41, up 46 cents, or 9%, after reaching a midday high of 5.56, on 10.9 million shares traded. Strong volume pushed it to break out of a little wedge. Now, we have the objective of getting through 5.65, and making a run to the main spike-high at 6.29. if it gets through that, we’re looking at 7.00 as the next target.
2. Inovio Pharmaceuticals
Inovio Pharmaceuticals (NASDAQ:INO), another vaccine stock, popped on Tuesday to 24.09, up 3.16, or 15%, with a session high of 24.99, on 62 million shares traded. If momentum and the channel are correct, this stock is headed to 38 next.
3. MOGU
MOGU (NYSE:MOGU), late in the day on Tuesday, exploded to 5.92, up 3.03, or 105%, after reaching all-time and session high highs at 6.85, on 22.4 million shares traded. It went from 2.61 to 6.85, a huge day for this stock, and a clean breakout, indeed. The next target is about 8.00.
4. Novavax
Novavax (NASDAQ:NVAX), yet another vaccine stock, the biggest and best I’ve seen all year, on Tuesday exploded 25.12, or 32%, to 104.56, with an all-time and session high of 111.77, on 26.3 million shares traded. Going from 4 to 111 is a fantastic move for a 6-month run. It seems to me that when this stock coiled and broke out, I said the way this stock looked, if it reached to the top of the channel it could be over 100. It reached 111.77 on a massive order from the government.
5. TG Therapeutics
TG Therapeutics (NASDAQ:TGTX) broke out on Tuesday and ran up 2.17, or 11%, to 22.52, with an all-time and session high of 22.78, on 3.2 million shares traded. TGTX, at this point, is running. My first target is 26.
6. Vaxart
Vaxart (NASDAQ:VXRT) was a monster on Tuesday, particularly late in the day. It ran up 2.43, or 38%, to 8.87, on 52.6 million shares traded, and then backed off in after-hours. It went from 7.50 to the session high at 8.98. Nevertheless, it had a strong pop a week and a half ago, then had a one-week long pull-back falling wedge, filled the gap and retested, and then popped. This pop is important. Above 9 3/4, and this looks like a 14-dollar stock again.
On the long side
Altimmune, Inc. (NASDAQ:ALT), BioCryst Pharmaceuticals, Inc. (BCRX), BiondVax Pharmaceuticals Ltd. (BVXV), CPS Technologies Corporation (CPSH), Cardiff Oncology, Inc. (CRDF), Cytokinetics, Incorporated (NASDAQ:CYTK), Arcimoto, Inc. (NASDAQ:FUV), Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), Inovio Pharmaceuticals, Inc. (INO), Livongo Health, Inc. (NASDAQ:LVGO), MOGU Inc. (MOGU), MTBC, Inc. (NASDAQ:MTBC), NIO Inc. (NIO), Niu Technologies (NASDAQ:NIU), Intellia Therapeutics, Inc. (NASDAQ:NTLA), Novavax, Inc. (NVAX), Overstock.com, Inc. (NASDAQ:OSTK), Origin Agritech Limited (SEED), TG Therapeutics, Inc. (TGTX), VBI Vaccines Inc. (NASDAQ:VBIV), and Vaxart (VXRT).